ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 38,330 employees in 142 locations in 53 countries as at December 31, 2021.

For further information about ICON, visit: www.iconplc.com

The University of Iowa Pharmaceuticals (UIP) is the largest and most experienced university-affiliated FDA-registered pharmaceutical manufacturing facility in the United States. UIP has been developing formulations, manufacturing products, and conducting analytical testing in compliance with current Good Manufacturing Practices (cGMPs) for 40 years. The facility is the only one of its kind offering the range and scope of services needed by commercial clients.

To learn more, visit https://uip.pharmacy.uiowa.edu/

Lumanity provides scientific product stewardship to help companies and counsel achieve timely and successful healthcare product approvals/introductions, maximize market potential of existing products, comply with regulations, and defend products from science-based challenges. Our dedicated scientific and regulatory consultants have extensive experience serving both industry and counsel on issues related to a diverse array of regulated products — including pharmaceuticals, medical devices, chemicals, cosmetics, foods, and dietary supplements. Our services span the entire product lifecycle — from technology identification and development to approval and post-market, product stewardship.